Australian Clinical Labs Limited (ACL) To Go Ex-Dividend on March 26th

Australian Clinical Labs Limited (ASX:ACL) declared a interim dividend on Thursday, February 27th, MarketIndexAU Dividends reports. Stockholders of record on Tuesday, April 15th will be given a dividend of 0.035 per share on Tuesday, April 15th. This represents a dividend yield of 1.07%. The ex-dividend date of this dividend is Wednesday, March 26th. This is a 16.7% increase from Australian Clinical Labs’s previous interim dividend of $0.03.

Australian Clinical Labs Price Performance

The company has a market capitalization of $728.27 million, a PE ratio of 30.38, a P/E/G ratio of -0.36 and a beta of 1.18. The company has a current ratio of 0.64, a quick ratio of 0.53 and a debt-to-equity ratio of 174.00.

About Australian Clinical Labs

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.